| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.06 |